Importance of β- Lactamases and Clinical Implications of their Inhibitors J. D. Williams Problems of Resistance in clinical Infection 15 December 2012 Pages: 3 - 11
β-Lactamases in Clinical Isolates Spectrum Implications of Sulbactam/Ampicillin J. F. AcarL. GutmannM.-D. Kitzis Problems of Resistance in clinical Infection 15 December 2012 Pages: 12 - 16
In Vitro Evaluations of Aminopenicillin/β-Lactamase Inhibitor Combinations Ronald N. Jones Problems of Resistance in clinical Infection 15 December 2012 Pages: 17 - 26
Discussion — Problems of Resistance in Clinical Infections Problems of Resistance in clinical Infection 15 December 2012 Pages: 27 - 28
Comparative Pharmacokinetics of Sulbactam/ Ampicillin and Clavulanic Acid/Amoxycillin in Human Volunteers B. HampelH. LodeP. Koeppe Section 2: Pharmacology of Sulbactam 15 December 2012 Pages: 29 - 33
Discussion — Pharmacology of Sulbactam Section 2: Pharmacology of Sulbactam 15 December 2012 Pages: 34 - 34
Sulbactam/Ampicillin in Paediatric Infections Adnan S. Dajani Section 3: Clinical Profiles of Sulbactam/Ampicillin 15 December 2012 Pages: 35 - 38
Sulbactam/Ampicillin versus Cefoxitin for Uncomplicated and Complicated Acute Pelvic Inflammatory Disease D. L. HemsellM. C. HeardB. J. Nobles Section 3: Clinical Profiles of Sulbactam/Ampicillin 15 December 2012 Pages: 39 - 42
Discussion — Clinical Profiles of Sulbactam/Ampicillin Section 3: Clinical Profiles of Sulbactam/Ampicillin 15 December 2012 Pages: 43 - 45
Sulbactam/Ampicillin versus Cefotaxime as Initial Therapy in Serious Soft Tissue, Joint and Bone Infections L. LöfflerA. BauernfeindW. Keyl Section 3: Clinical Profile of Sulbactam/Ampicillin 15 December 2012 Pages: 46 - 52
Sulbactam/Ampicillin in the Treatment of Lower Respiratory Infections M. A. Castellano Section 3: Clinical Profile of Sulbactam/Ampicillin 15 December 2012 Pages: 53 - 56
Clinical Experience with Intramuscular Sulbactam/Ampicillin in the Outpatient Treatment of Various Infections A Multicentre Trial M. F. Güneren Section 3: Clinical Profile of Sulbactam/Ampicillin 15 December 2012 Pages: 57 - 68
Discussion — Clinical Profiles of Sulbactam/Ampicillin Section 3: Clinical Profile of Sulbactam/Ampicillin 15 December 2012 Pages: 69 - 70
Sulbactam and Clavulanic Acid: Studies of Enzyme Kinetics and Synergy with Ampicillin and Mezlocillin W. CullmannM. StieglitzW. Opferkuch Short Communication 15 December 2012 Pages: 71 - 76
Sulbactam/Ampicillin in the Treatment of Epidemic Meningococcal Meningitis in Northern Nigeria A. I. DutseY. M. FakunleC. S. S. Bello Posters 15 December 2012 Pages: 77 - 79
Clinical and Pharmacokinetic Studies of Sulbactam/Penicillin Combinations in the Treatment of Ear, Nose and Throat Infections P. FederspilM. SchedlerE. Tiesler Posters 15 December 2012 Pages: 80 - 83
An Open Evaluation Study of Sulbactam/Ampicillin with or without Probenecid in the Treatment of Gonococcal Infections in Lagos Tolu Odugbemi Posters 15 December 2012 Pages: 89 - 91
Use of Sulbactam/Ampicillin in the Treatment of Uncomplicated Gonococcal Infection N. A. RotowaM. C. AsuzuA. Osoba Posters 15 December 2012 Pages: 92 - 93